1 mg tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly 1 mg tirzepatide microdose Tirzepatide

Cigna : Provides coverage contingent on medical necessity documentation

Some states have covered GLP-1 therapy for obesity, while others have narrowed or ended coverage because of cost

At Continental Hospitals, we do not just prescribe tirzepatide

Combining glutathione and tirzepatide together isn't FDA-approved as a combined therapy, and no Phase III trials have tested them in tandem

Ozempic Singapore: A New Contender in Weight Loss and Blood Sugar Control Ozempic (semaglutide injection) is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been shown to be effective in reducing body weight and improving blood sugar control